Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Goodwill (2020 - 2025)

Maravai Lifesciences Holdings has reported Goodwill over the past 6 years, most recently at $129.4 million for Q4 2025.

  • Quarterly results put Goodwill at $129.4 million for Q4 2025, down 19.05% from a year ago — trailing twelve months through Dec 2025 was $129.4 million (down 19.05% YoY), and the annual figure for FY2025 was $129.4 million, down 19.05%.
  • Goodwill for Q4 2025 was $129.4 million at Maravai Lifesciences Holdings, roughly flat from $129.4 million in the prior quarter.
  • Over the last five years, Goodwill for MRVI hit a ceiling of $326.6 million in Q1 2023 and a floor of $3.4 million in Q1 2025.
  • Median Goodwill over the past 5 years was $253.9 million (2021), compared with a mean of $224.9 million.
  • Biggest five-year swings in Goodwill: surged 85.71% in 2022 and later tumbled 98.96% in 2025.
  • Maravai Lifesciences Holdings' Goodwill stood at $152.8 million in 2021, then surged by 85.71% to $283.7 million in 2022, then grew by 14.92% to $326.0 million in 2023, then tumbled by 50.96% to $159.9 million in 2024, then dropped by 19.05% to $129.4 million in 2025.
  • The last three reported values for Goodwill were $129.4 million (Q4 2025), $129.4 million (Q3 2025), and $129.4 million (Q2 2025) per Business Quant data.